Electrocardiogram as a predictor of survival without appropriate shocks in primary prophylactic ICD patients: A retrospective multi-center study
Pelli, Ari; Kenttä, Tuomas V; Junttila, M Juhani; Bergau, Leonard; Zabel, Markus; Malik, Marek; Reichlin, Tobias; Willems, Rik; Vos, Marc A; Harden, Markus; Friede, Tim; Sticherling, Christian; Huikuri, Heikki V
(2020) International Journal of Cardiology, volume 309, pp. 78 - 83
(Article)
Abstract
Background: Abnormal 12-lead electrocardiogram (ECG) can predict cardiovascular events, including sudden cardiac death. We tested the hypothesis that ECG provides useful information on guiding implantable cardioverter defibrillator (ICD) therapy into individuals with impaired left ventricular ejection fraction (LVEF). Methods: Retrospective data of primary prevention ICD implantations from 14 European centers
... read more
were gathered. The registry included 5111 subjects of whom 1687 patients had an interpretable pre-implantation ECG available (80.0% male, 63.3 ± 11.4 years). Primary outcome was survival without appropriate ICD shocks or heart transplantation. A low-risk ECG was defined as a combination of ECG variables that were associated with the primary outcome. Results: A total of 1224 (72.6%) patients survived the follow-up (2.9 ± 1.7 years) without an ICD shock, 224 (13.3%) received an appropriate shock and 260 (15.4%) died. Low-risk ECG defined as QRS duration <120 ms, QTc interval <450 ms for men and <470 ms for women, and sinus rhythm, were met by 515 patients (30.5%). Multivariable Cox regression showed that the hazard (HR) for death, heart transplantation or appropriate shock were reduced by 42.5% in the low-risk group (HR 0.575; 95% CI 0.45–0.74; p < 0.001), compared to the high-risk group. The HR for the first appropriate shock was 42.1% lower (HR 0.58; 95% CI 0.41–0.82; p = 0.002) and the HR for death was 48.0% lower (HR 0.52; 95% CI 0.386–0.72; p < 0.001) in the low-risk group. Conclusion: Sinus rhythm, QRS <120 ms and normal QTc in standard 12-lead ECG provides information about survival without appropriate ICD shocks and might improve patient selection for primary prevention ICD therapy.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Ejection fraction, Heart failure, Implantable cardioverter-defibrillator, Mortality, Prediction, Cardiology and Cardiovascular Medicine, Journal Article
ISSN: 0167-5273
Publisher: Elsevier Ireland Ltd
Note: Funding Information: Retrospective data of primary prevention ICD implantations from 14 European centers in 11 European countries were gathered as a part of the ongoing EU-CERT-ICD study ( ClinicalTrials.gov Identifier: NCT02064192 ) funded by the European Community's Framework Programme FP7/2007–2013 (grant agreement number 602299). The compiled registry included 5111 recipients of primary preventive ICD between 2002 and 2014 [ 15 ]. Out of these patients 2041 had a digital pre-implantation ECG available for analysis. Patients with missing ID, missing follow-up data, duplicated measurements or paced rhythm were excluded. After exclusions, a total of 1687 patients from five European centers were included in the analyses. The population included both ischemic (n = 1092) and non-ischemic (n = 595) patients, and patients with cardiac resynchronization therapy defibrillator (CRT-D, n = 685) and single chamber (VVI)-ICD or dual chamber pacemaker (DDD)-ICD. Funding Information: The EU-CERT-ICD project is funded by the European Union 7th Framework Programme FP7/2007–2013 (grant agreement number 602299 ). Publisher Copyright: © 2020 Elsevier B.V. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
(Peer reviewed)